LONDON’S LARGEST CHARITY CYCLE EVENT GEARING UP TO BE THE BIGGEST YET
London’s largest charity cycling event, the London Bikeathon will return on Sunday 15 September, with 7,000 cyclists aiming to raise over £750,000 for blood cancer charity, Leukaemia & Lymphoma Research.
Now in its 17th year, the London Bikeathon is expected to attract an impressive number of cyclists who will pass by some of the Capital’s most iconic and picturesque sights, including St. Paul’s Cathedral, the London Eye, Big Ben, Tate Britain and Royal Festival Hall.
The prestigious event starts and finishes in the stunningly beautiful grounds of the Royal Hospital Chelsea, and offers something for everyone. Cyclists can choose from a cycling marathon of 26 miles, 52 miles, and for the first time this year, an extremely challenging, epic 100 mile bike ride route for those who really want to step up a gear.
Younger riders are also encouraged to take part on the day by entering the children’s challenge, where they can ride around a vehicle-free circuit within the grounds of the Royal Hospital Chelsea, and make the most of the festival vibe and live music.
Dan Solley, Head of Sports Events at Leukaemia & Lymphoma Research, says: “This year’s London Bikeathon looks set be our biggest yet and it will be an incredible sight to see 7,000 Unstoppable cyclists set off on their route from the Royal Hospital. Every penny raised for Leukaemia & Lymphoma Research will help us in our mission to beat blood cancer – stopping people from dying and making patients’ lives better. Sign up today and join us, it’ll be a day to remember!”
Last year, over 5,000 cyclists took to the streets of London for the flagship event, smashing the fundraising record and raising £735,000 to help beat blood cancer. It is hoped this year’s event will eclipse this total.
To sign up to the London Bikeathon today and join their Unstoppable team, please visit
About Leukaemia & Lymphoma Research
“Leukaemia & Lymphoma Research’s vision is to beat blood cancer. To do this, our mission is clear.
We stop people dying from blood cancer, we work to improve patients’ quality of life until blood cancer no longer has an impact, and we search for ways to prevent people getting blood cancer in the first place.
We do this by inspiring new treatments and better care, driving faster and smarter diagnosis, and by being the voice of influence and championing the needs of all patients, including the 30,000 patients who are newly diagnosed each year.
In the 53 years since we began this journey, we have made some world leading discoveries. Today, we continue to develop new ways of working to beat blood cancer, such as our innovative Trials Acceleration Programme that helps more patients get on clinical trials and access the newest medicines.
We are the UK’s largest charity dedicated to beating blood cancer, and we won’t stop until we’ve succeeded.”